Abstract:Background: Hantaan virus (HTNV, Orthohantavirus hantanensae species, Hantaviridae family) is the main etiological agent responsible for hemorrhagic fever with renal syndrome (HFRS). The novel HTNV may pose a potential danger to the control and prevention of HFRS in China, which highlights the importance of vaccine development in public health management. In previous studies, our laboratory discovered and successfully isolated a new HTNV strain, HV004 strain, from Apodemus agrarius captured in an epidemic area in Hubei, China. Methods: An initial biological and pathogenicity characterization of HTNV 76-118 (standard train), HV114 strain (a clinical isolate from Hubei province in 1986), and the novel isolate HV004 strain from the epidemic areas of Hubei province were performed in susceptible cells and in vivo. An experimental HV004 strain inactivated vaccine was prepared, and its corresponding immunogenicity was analyzed in BALB/c mice. Results: HV004 strain had a similar but higher pathogenicity than HTNV 76-118 and HV114 in suckling mice. A subcutaneous vaccination (s.c.) with the inactivated HTNV vaccine adjuvanted with aluminum, followed by a challenge intraperitoneally with 106 FFU/ml HTNV, afforded full protection against an HTNV challenge. All immunized mice in every group elicited serum neutralizing antibodies with increasing dosages, which may protect mice from HTNV infection. A dose-dependent stimulation index of splenocytes was also observed in immunized mice. The percentage of IFN-γ-producing CD3+CD8+ T cells was significantly higher in the spleens of immunized mice than in those of control mice. Conclusions: These findings suggest that the inactivated HTNV vaccine may stimulate mice to produce high levels of antibodies with neutralization activity and elicit specific anti-HTNV humoral and cellular immune responses in BALB/c mice against the prevalent strain of HTNV in south central China.

Specific interference shRNA-expressing plasmids inhibit Hantaan virus infection in vitro and in vivo

Lentiviral Vector-Derived Shrnas Confer Enhanced Suppression of Semliki Forest Virus Replication in Bhk-21 Cells Compared to Shrnas Expressed from Plasmids

Targeted Inhibition of Hantavirus Replication and Intracranial Pathogenesis by a Chimeric Protein-Delivered Sirna.

Establishment of SYBR Green-Based Qpcr Assay for Rapid Evaluation and Quantification for Anti-Hantaan Virus Compounds in Vitro and in Suckling Mice

Inhibition of Foot and Mouth Disease Virus Replication in Vitro and in Vivo by Dual Short Hairpin RNA-Mediated RNA Interference

HTNV Sensitizes Host Toward TRAIL-Mediated Apoptosis-A Pivotal Anti-hantaviral Role of TRAIL.

Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus

A comprehensive investigation of Glycoprotein-based nucleic acid vaccines for Hantaan Virus

An algal lectin griffithsin inhibits Hantaan virus infection in vitro and in vivo

IFN-λs inhibit Hantaan virus infection through the JAK-STAT pathway and expression of Mx2 protein

Inhibition of Porcine Hemagglutinating Encephalomyelitis Virus Replication by Short Hairpin RNAs Targeting of the Nucleocapsid Gene in a Porcine Kidney Cell Line

Pathogenicity of novel hantavirus isolate and antigenicity and immunogenicity of novel strain-based inactivated vaccine

A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of Hantaan virus induced protective immunity in mice

Inhibition of Porcine Hemagglutinating Encephalomyelitis Virus (HEV) Replication by Sirna Targeting the Spike Glycoprotein (S) Gene in N2a Cells

Inhibition of Porcine Reproductive and Respiratory Syndrome Virus Replication by Short Hairpin RNA Targeting to M Protein Gene

MicroRNA let-7a regulation of Hantaan virus replication by Targeting FAS Signaling Pathways

Inhibition of Encephalomyocarditis Virus Replication by Shrna Targeting 1C and 2A Genes in Vitro and in Vivo

Hantaan virus inhibits type I interferon response by targeting RLRs signaling pathways through TRIM25

Hantaan Virus Inhibits Type I Interferon Response by Targeting RLR Signaling Pathways Through TRIM25

Inhibition of Porcine Reproductive and Respiratory Syndrome Virus Replication by Short Hairpin RNA in MARC-145 Cells.

Short Communication: Efficiently Inhibiting HIV-1 Replication by a Prototype Foamy Virus Vector Expressing Novel H1 Promoter-Driven Short Hairpin RNAs